Introduction
Malacoplakia is a rare chronic inflammatory disease that most commonly involves the genitourinary tract, but also affects other systems, including the gastrointestinal tract, lungs, thyroid, and skin (1) .
Urological malacoplakia has a myriad of clinical presentations, depending on the location of the disease, and can involve any portion of the urinary tract with the bladder being most commonly involved, followed by the renal parenchyma, the ureter, and the renal pelvis.
Irritative bladder symptoms, flank pain, palpable mass, hematuria and fever are commonly presented complaints.
Misdiagnosis is common, as the lesions are often mistaken for renal abscesses or malignant growths, especially when there is concomitant lung involvement that can mimic metastatic disease.
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Cavallone et al 37 composed primarily of calcium and iron salts. Therefore, the diagnosis of malacoplakia is made based on histological analysis.
Case description
A 65-year-old woman presented uremic symptoms related to obstructive nephropathy with ultrasonography bilateral hydroureteronephrosis. Blood analysis revealed a serum creatinine level of 9.3 mg/dL with hyperkalemia (K+ 6.7 mEq/L) and anemia with hemoglobin of 7 g/dL.
Urine culture grew pansensitive E. coli treated with specific chinolonic antibiotics.
Over the previous 6 months, the patient reported some urinary frequency with gross hematuria in a history of recurrent UTI treated with antibiotics not well specified. She had a history of: hypertension, diabetes with diet therapy, obesity, previous cholecystectomy for cholelithiasis, smoking. She denied drug allergies.
She initially underwent bilateral nephrostomy-tube placement with improvement in her renal function followed by left ureteral stenting and infructuous right ureteral stenting using the antegrade approach, for the presence of proximal and distal ureteral stenosis.
A computerized tomography (CT) scan with contrast of the abdomen and pelvis showed the kidney with thinning parenchyma, a thickening bladder wall with exophytic lesions in anterior wall. The chest radiography was normal.
Cystoscopy confirmed the presence of multiple lesions protruding from the anterior and left lateral bladder wall. Distal left ureteral stenting born from a normal left ureteral orifice. The right ureteral orifice was well visualized. Histological examination revealed a transurethral resection of the suspect areas of bladder with de-epithelialization aspects with a proliferation of foamy histiocytes with PAS-positive intracytoplasmic granules. Based on these histopathological findings, the diagnosis of malacoplakia was made.
After some weeks, right ureteral recanalization after balloon dilation of strictures with placement of ureteral stent was performed.
The patient was discharged with bilateral ureteral stenting, serum creatinine level was 1.83 mg/dL, hemoglobin 12.9 g/dL.
The treatment was continued with ascorbic acid 500 mg day and ciprofloxacin 500 mg once daily antibiotics for one month.
Conclusions
Malacoplakia is a rare disease with a wide spectrum of clinical presentations and the suspect must be considered especially in women with a histoty of UTI and immunodeficiency.
The diagnosis is only histological. The treatment is not standard but depends on the location of disease. Malacoplakia isolated to the lower genitourinary tract, after a transurethral resection indicating to obtain a biopsy but also to debulking, can typically be treated with medications, whereas upper tract disease (involving the kidneys and ureters) commonly requires a combination of medical and surgical intervention.
Pharmaceutical treatment of malacoplakia uses ascorbic acid and antibiotics with activity directed especially against Gram-negative bacteria and antibiotics that have high bioavailability within macrophages. Sulfonamides and quinolones, especially fluoroquinolones, are most frequently used because they penetrate well into macrophages. No consensus exists on the optimal duration of treatment, with previous case reports treating patients from 4 weeks to 6 months.
